Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

British American Tobacco

Imperial Brands PLC

The U.S. Food and Drug Administration announced Thursday that it will propose a ban on menthol-flavored cigarettes in the United States.

FDA to propose ban on menthol-flavored cigarettes

The U.S. Food and Drug Administration on Thursday proposed a ban on menthol cigarettes in the United States, a win for anti-tobacco and civil rights groups, but a move that could erase a huge chunk of sales for cigarette manufacturers.

U.S. FDA proposes ban on menthol cigarettes

Altria (MO) delivered earnings and revenue surprises of 2.88% and -2.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Q1 Earnings Surpass Estimates

Altria first-quarter earnings declined as revenue fell short of estimates as cigarette shipments continue to decline.

Marlboro parent Altria revenue falls short as cigarette shipments decline, buys rest of On nicotine pouch

Shares of Altria Group (NYSE:MO) moved higher by 0.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 1.83% over the past year to $1.07, which beat the estimate of $1.05.

Recap: Altria Group Q1 Earnings

Altria Group Inc. said Thursday it had net income of $1.424 billion, or 77 cents a share, in the first quarter, down from $1.552 billion, or 83 cents a share, in the year-earlier period. Adjusted per-share earnings came to $1.07, ahead of the $1.05 FactSet consensus.

Altria profit beats as revenue falls short and company sticks with full-year guidance

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ACQUIRES--ALTRIA REPORTS 2021 FIRST-QUARTER RESULTS; REAFFIRMS 2021 EARNINGS GUIDANCE; ACQUIRES REMAINING 20% OF GLOBAL on! BUSINESS

Altria Reports 2021 First-Quarter Results; Reaffirms 2021 Earnings Guidance; Acquires Remaining 20% of Global on! Business

Altria stock (NYSE: MO) dropped more than 9% in just the last one week (five trading days) and currently trades at $47 per share. MO stock dropped after news reports came out saying the Joe Biden administration is considering new restrictions on tobacco products sold in the U.S. Sources claimed.

How U.S. Government Tobacco Restrictions Drove A Slide In Altria Stock

Caterpillar

McDonald's

Merck

A quick glance at the calendar for this week shows some 900 publicly traded companies are scheduled to report March quarter earnings this week.

Earnings Previews: Altria, Caterpillar, McDonald's, Merck

Cloudera

Editas Medicine

KraneShares CSI China Internet ETF

Roku

VanEck Low Carbon Energy ETF

Tencent Music Entertainment Group 

Broader markets be at all-time highs, but there are still opportunities for the coming months. Here are seven stocks to buy this May.

7 Stocks to Buy for May

D.R. Horton

Kearny Financial

Limestone Bancorp Inc

UPS saw its shares surge over 9% after reporting a blowout quarter with revenue growth of 27%. As investors anticipate earnings from other tech giants like Alphabet and Microsoft, Q.ai's deep learning algorithms have found today's top buys.

Top Stocks To Buy Today As UPS Earnings Send Market Higher

Broadmark Realty Capital Inc.

AT&T

How does a 7.8% dividend yield or a 7.3% one sound?

3 Great Income Stocks to Buy Right Now

Altria's (MO) first-quarter performance is likely to have been affected by headwinds in cigarette and wine categories.

Factors to Know Ahead of Altria's (MO) Q1 Earnings Release

Aphria

Canopy Growth

Cronos Group

Amplify Alternative Harvest ETF

Constellation Brands

Tilray Brands

Marijuana stocks have been hot and cold for years. Coming off a strong stretch, investors hope the group -- including these seven marijuana stocks -- can find its footing and go higher.

7 Marijuana Stocks To Buy As Usage Moves Mainstream

Altria has had a tough week in the news on the back of proposed regulation to lower nicotine rates and increase taxes. The company's cigarette business has remained remarkably stable and the company's alcohol business is strong. It has significant potential in its marijuana business.

Altria Can Handle Changing Nicotine Levels, It Could Be A Growth Play

Mrs. Scheiber achieved 18.3% CAGR annual returns for 50 years – just 2.5% less than Warren Buffett. Believe it or not, you can do the same.

4 Reasons Altria Is A 7.3% Yield Retirees Can Trust

Tobacco stocks have recently come under fire amid renewed fears about tougher regulation in the shape of reduced nicotine levels and higher cigarette taxes. Investors need to take regulation plans seriously.

Altria: Investors Need To Take Regulation Plans Seriously

Costco

Genuine Parts

Vanguard Dividend Appreciation ETF

Valero Energy

Vanguard High Dividend Yield ETF

SPDR S&P 500 ETF Trust

Dividend-focused investing is currently more popular than it has been in decades. In this article, I share four situations when dividends play an important role in my investment process.

The Four Cases When Dividends Matter

A judge is likely to give the green light for the suit to proceed.

Altria and Juul Labs Targeted by $13 Billion Antitrust Lawsuit

Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Altria (MO) Q1 Earnings Expected to Decline

Kansas City Southern

Markets were sharply lower on Wall Street.

Full Steam Ahead for Kansas City Southern; Tobacco Stocks Fall on Regulation Fears

Altria Group stock is being dragged down by President Joe Biden's potential plans to curb nicotine content in cigarettes.

What Lower Nicotine Levels in Cigarettes Could Mean for Altria Stock

Tobacco stock Altria Group Inc (NYSE:MO) is under pressure today, one of many in its sector reeling amid reports from the White House dealing with nicotine levels.

MO Extends Losses Amid Possible Nicotine Level Cap

Shares of Altria shares stretched losses early Tuesday following a report that the Biden administration may require cigarette and tobacco companies to cut down the amount of nicotine in cigarettes sold in the US. The administration wants lower nicotine levels to make cigarettes less addictive and it is also considering a ban on menthol cigarettes, according to a Wall Street Journal report Monday, citing unnamed sources familiar with the matter.  The ban on menthol cigarettes would be aimed at curbing smoking among young people, the Journal reported.

Altria extends losses as Biden administration considers forcing cigarette makers to slash nicotine levels

Philip Morris

Tobacco stocks like MO stock and PM stock are suffering Tuesday following reports that the FDA could cut nicotine levels in cigarettes. The post Tobacco Stocks: Why PM, IMBBY, BTI, MO Stocks Are Getting Smoked Today appeared first on InvestorPlace.

News for Altria Stock (MO)